Literature DB >> 25311140

Lewy body disease and dementia with Lewy bodies.

Kenji Kosaka1.   

Abstract

In 1976 we reported our first autopsied case with diffuse Lewy body disease (DLBD), the term of which we proposed in 1984. We also proposed the term "Lewy body disease" (LBD) in 1980. Subsequently, we classified LBD into three types according to the distribution pattern of Lewy bodies: a brain stem type, a transitional type and a diffuse type. Later, we added the cerebral type. As we have proposed since 1980, LBD has recently been used as a generic term to include Parkinson's disease (PD), Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB), which was proposed in 1996 on the basis of our reports of DLBD.DLB is now known to be the second most frequent dementia following Alzheimer's disease (AD).In this paper we introduce our studies of DLBD and LBD.

Entities:  

Mesh:

Year:  2014        PMID: 25311140      PMCID: PMC4275567          DOI: 10.2183/pjab.90.301

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  33 in total

Review 1.  Invited Article: Nervous system pathology in sporadic Parkinson disease.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Neurology       Date:  2008-05-13       Impact factor: 9.910

2.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

Review 3.  Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies.

Authors:  I G McKeith; E K Perry; R H Perry
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

4.  Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb.

Authors:  Renpei Sengoku; Yuko Saito; Masako Ikemura; Hiroyuki Hatsuta; Yoshio Sakiyama; Kazutomi Kanemaru; Tomio Arai; Motoji Sawabe; Noriko Tanaka; Hideki Mochizuki; Kiyoharu Inoue; Shigeo Murayama
Journal:  J Neuropathol Exp Neurol       Date:  2008-11       Impact factor: 3.685

5.  The incidence and characteristics of Lewy bodies in idiopathic paralysis agitans (Parkinson's disease).

Authors:  J BETHLEM; W A DEN HARTOG JAGER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

6.  Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria.

Authors:  Dag Aarsland; Arvid Rongve; Sabine Piepenstock Nore; Ragnhild Skogseth; Siri Skulstad; Uwe Ehrt; Dagne Hoprekstad; Clive Ballard
Journal:  Dement Geriatr Cogn Disord       Date:  2008-10-31       Impact factor: 2.959

Review 7.  DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.

Authors:  C F Lippa; J E Duda; M Grossman; H I Hurtig; D Aarsland; B F Boeve; D J Brooks; D W Dickson; B Dubois; M Emre; S Fahn; J M Farmer; D Galasko; J E Galvin; C G Goetz; J H Growdon; K A Gwinn-Hardy; J Hardy; P Heutink; T Iwatsubo; K Kosaka; V M-Y Lee; J B Leverenz; E Masliah; I G McKeith; R L Nussbaum; C W Olanow; B M Ravina; A B Singleton; C M Tanner; J Q Trojanowski; Z K Wszolek
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

8.  Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

Authors:  Zuzana Walker; Evelyn Jaros; Rodney W H Walker; Lean Lee; Durval C Costa; Gill Livingston; Paul G Ince; Robert Perry; Ian McKeith; Cornelius L E Katona
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-12       Impact factor: 10.154

Review 9.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

10.  Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice.

Authors:  Kelvin C Luk; Victoria M Kehm; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M Y Lee
Journal:  J Exp Med       Date:  2012-04-16       Impact factor: 14.307

View more
  8 in total

Review 1.  Sleep, Cognition and Dementia.

Authors:  Verna R Porter; William G Buxton; Alon Y Avidan
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 2.  Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.

Authors:  Md Nematullah; M N Hoda; Farah Khan
Journal:  Mol Neurobiol       Date:  2017-02-21       Impact factor: 5.590

Review 3.  Lewy Body Dementias: Controversies and Drug Development.

Authors:  Shannon Y Chiu; Dawn Bowers; Melissa J Armstrong
Journal:  Neurotherapeutics       Date:  2021-12-02       Impact factor: 6.088

Review 4.  Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.

Authors:  Teresa R Kee; Pamela Espinoza Gonzalez; Jessica L Wehinger; Mohammed Zaheen Bukhari; Aizara Ermekbaeva; Apoorva Sista; Peter Kotsiviras; Tian Liu; David E Kang; Jung-A A Woo
Journal:  Front Aging Neurosci       Date:  2021-04-22       Impact factor: 5.750

Review 5.  Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.

Authors:  Rimona S Weil; Tammaryn L Lashley; Jose Bras; Anette E Schrag; Jonathan M Schott
Journal:  F1000Res       Date:  2017-08-30

6.  Human Brain Lipidomics: Pilot Analysis of the Basal Ganglia Sphingolipidome in Parkinson's Disease and Lewy Body Disease.

Authors:  Aaron W Beger; Beatrix Dudzik; Randall L Woltjer; Paul L Wood
Journal:  Metabolites       Date:  2022-02-18

7.  Promising Molecular Targets for Pharmacological Therapy of Neurodegenerative Pathologies.

Authors:  M E Neganova; Yu R Aleksandrova; V O Nebogatikov; S G Klochkov; A A Ustyugov
Journal:  Acta Naturae       Date:  2020 Jul-Sep       Impact factor: 1.845

8.  Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases.

Authors:  Zen-Ichi Tanei; Yuko Saito; Shinji Ito; Tomoyasu Matsubara; Atsuko Motoda; Mikihiro Yamazaki; Yasuhiro Sakashita; Ito Kawakami; Masako Ikemura; Shinya Tanaka; Renpei Sengoku; Tomio Arai; Shigeo Murayama
Journal:  Acta Neuropathol       Date:  2020-11-05       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.